Top Markets
Coin of the day
Recro Pharma, Inc. Recro Pharma, Inc.

Recro Pharma, Inc.

REPH
Classement en actions #25706
Recro Pharma, Inc. operates as a contract development and manufacturing... Recro Pharma, Inc. operates as a contract development and manufacturing organization (CDMO), offering comprehensive services for the development, production, and packaging of diverse therapeutic dosage forms. The company primarily specializes in small molecule therapeutic development, serving both domestic U.S. and international clients. Its extensive capabilities encompass a wide array of formats, including oral solid doses, sterile injectable solutions, oral liquid preparations, tablets, topical formulations, liquid/powder-filled capsules, ophthalmic droppers, liposomal products, and nano/microparticles. Furthermore, Recro Pharma provides specialized services such as aseptic fill/finish, lyophilization (freeze-drying), final packaging, and logistics management. Originally founded as Recro Pharma I, Inc., the company underwent a name change to Recro Pharma, Inc. in August 2008. The organization was established in 2007 and is headquartered in Exton, Pennsylvania.
Prix de l'action
$2.09
Dernière synchronisation: 2022-03-21
Capitalisation boursière
$47.04M
Changement (1 jour)
-0.48%
Changement (1 an)
0.00%
Pays
US
Échange Recro Pharma, Inc. (REPH)

Catégorie

Historique des dividendes pour Recro Pharma, Inc. (REPH)
Recro Pharma, Inc. (symbole boursier : REPH) a versé un total de 0 dividendes.
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : 0.00
Rendement du dividende (TTM) : 0
Versements de dividendes pour Recro Pharma, Inc. (REPH) de 2026 à 2026
Versements annuels de dividendes
Année Dividende (ajusté pour divisions d’actions) Changez
Pas assez de données pour les dates fournies.
Liste de tous les paiements de dividendes
Année Dividende Changez
Pas assez de données pour les dates fournies.
Dividendes versés par des entreprises similaires ou concurrentes